ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 82 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,923,000 | -58.0% | 2,575,000 | -19.9% | 0.15% | -58.9% |
| Q2 2021 | $14,116,000 | -39.5% | 3,215,434 | 0.0% | 0.36% | -48.5% |
| Q1 2021 | $23,344,000 | +203.7% | 3,215,434 | +71.9% | 0.70% | +102.0% |
| Q3 2020 | $7,686,000 | -22.4% | 1,870,000 | +13.3% | 0.34% | -41.3% |
| Q2 2020 | $9,900,000 | +34.8% | 1,650,000 | +69.2% | 0.59% | -24.8% |
| Q1 2020 | $7,342,000 | -34.9% | 975,000 | +18.9% | 0.78% | -24.9% |
| Q4 2019 | $11,275,000 | -99.7% | 820,000 | +164.5% | 1.04% | +172.2% |
| Q3 2019 | $3,682,800,000 | +163.2% | 310,000 | +210.0% | 0.38% | +190.8% |
| Q2 2019 | $1,399,000,000 | – | 100,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 4,081,972 | $9,388,000 | 2.74% |
| RA Capital Management | 11,028,722 | $25,366,000 | 0.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $15,984,000 | 0.31% |
| Avidity Partners Management LP | 3,836,798 | $8,825,000 | 0.20% |
| Casdin Capital, LLC | 2,575,000 | $5,923,000 | 0.15% |
| Vivo Capital, LLC | 1,325,736 | $3,049,000 | 0.14% |
| Artal Group S.A. | 1,803,858 | $4,149,000 | 0.09% |
| Eversept Partners, LP | 569,581 | $1,310,036 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 374,811 | $862,000 | 0.09% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,315 | $2,480,000 | 0.07% |